Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population.

Chen J, Shao P, Cao Q, Li P, Li J, Cai H, Zhu J, Wang M, Zhang Z, Qin C, Yin C.

PLoS One. 2012;7(7):e40817. doi: 10.1371/journal.pone.0040817. Epub 2012 Jul 18.

2.

Polymorphisms in the mTOR gene and risk of sporadic prostate cancer in an Eastern Chinese population.

Li Q, Gu C, Zhu Y, Wang M, Yang Y, Wang J, Jin L, Zhu ML, Shi TY, He J, Zhou X, Ye DW, Wei Q.

PLoS One. 2013 Aug 5;8(8):e71968. doi: 10.1371/journal.pone.0071968. Print 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/bc36c048-60e4-48a2-908d-6253e93df062.

3.

Associations of PI3KR1 and mTOR polymorphisms with esophageal squamous cell carcinoma risk and gene-environment interactions in Eastern Chinese populations.

Zhu J, Wang M, Zhu M, He J, Wang JC, Jin L, Wang XF, Xiang JQ, Wei Q.

Sci Rep. 2015 Feb 5;5:8250. doi: 10.1038/srep08250.

4.

Association of six susceptibility Loci with prostate cancer in northern chinese men.

Zhang YR, Xu Y, Yang K, Liu M, Wei D, Zhang YG, Shi XH, Wang JY, Yang F, Wang X, Liang SY, Zhao CX, Wang F, Chen X, Sun L, Zhu XQ, Zhu L, Yang YG, Tang L, Jiao HY, Huo ZH, Yang Z.

Asian Pac J Cancer Prev. 2012;13(12):6273-6.

5.

Genetic polymorphisms in HIF1A are associated with prostate cancer risk in a Chinese population.

Li P, Cao Q, Shao PF, Cai HZ, Zhou H, Chen JW, Qin C, Zhang ZD, Ju XB, Yin CJ.

Asian J Androl. 2012 Nov;14(6):864-9. doi: 10.1038/aja.2012.101. Epub 2012 Oct 8.

6.

A functional variant in the MTOR promoter modulates its expression and is associated with renal cell cancer risk.

Cao Q, Ju X, Li P, Meng X, Shao P, Cai H, Wang M, Zhang Z, Qin C, Yin C.

PLoS One. 2012;7(11):e50302. doi: 10.1371/journal.pone.0050302. Epub 2012 Nov 28.

7.

Genetic variations in the mTOR gene contribute toward gastric adenocarcinoma susceptibility in an Eastern Chinese population.

Wang MY, Li QX, He J, Qiu LX, Wang YN, Li J, Sun MH, Wang XF, Yang YJ, Wang JC, Jin L, Wei QY.

Pharmacogenet Genomics. 2015 Nov;25(11):521-30. doi: 10.1097/FPC.0000000000000163.

PMID:
26287940
8.

Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.

Hildebrandt MA, Yang H, Hung MC, Izzo JG, Huang M, Lin J, Ajani JA, Wu X.

J Clin Oncol. 2009 Feb 20;27(6):857-71. doi: 10.1200/JCO.2008.17.6297. Epub 2009 Jan 21.

9.

Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study.

Chen J, Cui X, Zhou H, Qin C, Cao Q, Ju X, Li P, Cai H, Zhu J, Meng X, Wang M, Zhang Z, Shao P, Li J, Yin C.

BMC Cancer. 2013 Jul 24;13:356. doi: 10.1186/1471-2407-13-356.

10.

Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer.

Kim JG, Chae YS, Sohn SK, Kang BW, Moon JH, Lee SJ, Jeon SW, Park JS, Park JY, Choi GS.

Oncology. 2010;79(3-4):278-82. doi: 10.1159/000320761. Epub 2011 Mar 16.

PMID:
21412012
11.

Genetic polymorphisms in IGF-I and IGFBP-3 are associated with prostate cancer in the Chinese population.

Qian J, Zhou H, Chen J, Ding Q, Cao Q, Qin C, Shao P, Li P, Cai H, Meng X, Ju X, Wang M, Zhang Z, Li J, Hua L, Yin C.

PLoS One. 2014 Feb 21;9(2):e85609. doi: 10.1371/journal.pone.0085609. eCollection 2014.

12.

Association between VHL single nucleotide polymorphism (rs779805) and the susceptibility to prostate cancer in Chinese.

Chen J, Wu Y, Shao P, Cao Q, Qin C, Li P, Ding Q, Zhu J, Wang M, Zhang Z, Li J, Yin C.

DNA Cell Biol. 2012 May;31(5):790-6. doi: 10.1089/dna.2011.1408. Epub 2011 Nov 15.

PMID:
22084938
13.

Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population.

He J, Wang MY, Qiu LX, Zhu ML, Shi TY, Zhou XY, Sun MH, Yang YJ, Wang JC, Jin L, Wang YN, Li J, Yu HP, Wei QY.

Mol Carcinog. 2013 Nov;52 Suppl 1:E70-9. doi: 10.1002/mc.22013. Epub 2013 Feb 19.

PMID:
23423739
14.

[Association of TET2, LMTK2 and FAM84B gene expression with prostate cancer risk in Chinese patients].

Wang NN, Wang JY, Shi XH, Zhang YG, Liu M, Wang X, Hui J, Chen X, Liang SY, Wei D, Yang F, Zhao F, Zhang YH, Yang Z.

Zhonghua Zhong Liu Za Zhi. 2013 Apr;35(4):262-7. doi: 10.3760/cma.j.issn.0253-3766.2013.04.005. Chinese.

PMID:
23985253
15.

Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes.

Wang LE, Ma H, Hale KS, Yin M, Meyer LA, Liu H, Li J, Lu KH, Hennessy BT, Li X, Spitz MR, Wei Q, Mills GB.

J Cancer Res Clin Oncol. 2012 Mar;138(3):377-85. doi: 10.1007/s00432-011-1103-0. Epub 2011 Dec 7.

16.

Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer.

Li Q, Yang J, Yu Q, Wu H, Liu B, Xiong H, Hu G, Zhao J, Yuan X, Liao Z.

Clin Cancer Res. 2013 Nov 15;19(22):6252-60. doi: 10.1158/1078-0432.CCR-13-1093. Epub 2013 Sep 27.

17.

Combined effects of genetic variants of the PTEN, AKT1, MDM2 and p53 genes on the risk of nasopharyngeal carcinoma.

Zhang X, Chen X, Zhai Y, Cui Y, Cao P, Zhang H, Wu Z, Li P, Yu L, Xia X, He F, Zhou G.

PLoS One. 2014 Mar 14;9(3):e92135. doi: 10.1371/journal.pone.0092135. eCollection 2014.

18.

A polymorphism (rs2295080) in mTOR promoter region and its association with gastric cancer in a Chinese population.

Xu M, Tao G, Kang M, Gao Y, Zhu H, Gong W, Wang M, Wu D, Zhang Z, Zhao Q.

PLoS One. 2013;8(3):e60080. doi: 10.1371/journal.pone.0060080. Epub 2013 Mar 29.

19.

Functional promoter rs2295080 T>G variant in MTOR gene is associated with risk of colorectal cancer in a Chinese population.

Xu M, Gao Y, Yu T, Wang J, Cheng L, Cheng L, Cheng D, Zhu B.

Biomed Pharmacother. 2015 Mar;70:28-32. doi: 10.1016/j.biopha.2014.12.045. Epub 2015 Jan 9.

PMID:
25776475
20.

Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men.

Na R, Liu F, Zhang P, Ye D, Xu C, Shao Q, Qi J, Wang X, Chen Z, Wang M, He D, Wang Z, Zhou F, Yuan J, Gao X, Wei Q, Yang J, Jiao Y, Ou-Yang J, Zhu Y, Wu Q, Chen H, Lu D, Shi R, Lin X, Jiang H, Wang Z, Jiang D, Sun J, Zheng SL, Ding Q, Mo Z, Sun Y, Xu J.

Prostate. 2013 Nov;73(15):1623-35. doi: 10.1002/pros.22629. Epub 2013 Sep 9.

Supplemental Content

Support Center